Ā | No. (%) | P value | |
---|---|---|---|
True acupuncture group (nā=ā68) | Sham aupuncture group (nā=ā66) | ||
Age, median (95% CI) | 60 (56.84ā~ā60.48) | 58 (54.99ā~ā60.04) | 0.653 |
Gender | Ā | Ā | 0.725 |
Male | 14 (20.6) | 12 (18.2) | Ā |
Female | 54 (79.4) | 54 (81.8) | |
Study site | Ā | Ā | ā |
Beijing hospital of traditional Chinese medicine | 22 (16.4) | 22 (16.4) | Ā |
Guangā anmen hospital | 9 (6.7) | 9 (6.7) | |
Beijing friendship hospital | 19 (14.2) | 16 (11.9) | |
Beijing shijitan hospital | 18 (13.4) | 19 (14.2) | |
TumorĀ pathologicalĀ type | Ā | Ā | 0.830 |
Breast cancer | 37 (54.4) | 35 (53.0) | Ā |
Ovarian malignant carcinoma | 8 (11.8) | 8 (12.1) | |
Cervical carcinoma | 1 (1.5) | 0 (0.0) | |
Endometrial carcinoma | 2 (2.9) | 2 (3.0) | |
Lung cancer | 20 (29.4) | 21 (31.8) | |
Cancer stage | Ā | Ā | 0.301 |
I | 12 (17.6) | 17 (25.8) | Ā |
II | 18 (26.5) | 16 (24.2) | |
III | 12 (17.6) | 11 (16.7) | |
IV | 26 (38.2) | 21 (31.8) | |
Prior chemotherapy | 33 (48.5) | 30 (45.5) | 0.721 |
Chemotherapy regimen contains | |||
Cis-platinum | 28 (41.1) | 17 (25.8) | 0.059 |
Anthracycline | 14 (20.6) | 19 (28.8) | 0.271 |
Taxane | 32 (47.0) | 38 (57.6) | 0.223 |